Annovis Bio, Inc. - שווי כולל של החברה ANVS
This daily price chart for Annovis Bio, Inc. (ANVS) reflects an enterprise value currently priced at 24.80. The business focuses on developing neuron restoration methods by optimizing intracellular transport. The project targets a massive untapped segment of dementia and tremor therapies. Intellectual property protections preclude pricing wars, leaving risks solely to potential scientific breakthroughs by other laboratories.
Annovis Bio, Inc. - פילוחים אנליטיים ומדדי מפתח (ANVS)
When screening assets, an investor evaluates the real value of a business by excluding market capitalization distortions. This metric sums the value of shares and debt, subtracting available cash. For Annovis Bio, Inc. (ANVS), which invests in the joint development of dementia drugs, this reflects the actual cost of acquiring the company. An analysis of market value, accounting for liquidity and liabilities on GURU.Markets, reveals the true dynamics of interest in the firm's biotechnological potential.